Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mu-Hsin Chang

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Cell Death Discovery|October 7, 2025
Targeting ESR1 restores SQSTM1-dependent autophagy and sensitizes ER-positive breast cancer to oxidative and radiation stressYi-Fang Yang, Zhao-Jing He, Han-Hsi Kuo, et al.
Journal of Cellular and Molecular Medicine|October 23, 2019
In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non-small-cell lung cancerTse-Hung Huang, Alexander T H Wu, Tai-Shan Cheng, et al.
Journal of the Chinese Medical Association : JCMA|April 18, 2025
Real-world experience in treatment outcome and genomic insights for metastatic prostate neuroendocrine carcinomaJiun-I Lai, Yu-Ching Peng, Peter Mu-Hsin Chang, et al.
Frontiers in Pharmacology|October 21, 2024
Dehydroepiandrosterone suppresses human colorectal cancer progression through ER stress-mediated autophagy and apoptosis in a p53-independent mannerThi-Huong Nguyen, Huey-Jiun Ko, Po-Yu Tsai, et al.
Cancer Chemotherapy and Pharmacology|May 26, 2009
Promising overall survival of patients with recurrent/metastatic squamous cell carcinoma of head and neck receiving gemcitabine plus cisplatin treatment: report of a multi-center phase II studyMuh-Hwa Yang, Peter Mu-Hsin Chang, Cheng-Hwai Tzeng, et al.
Scientific Reports|September 11, 2019
Clinical, pathophysiologic, and genomic analysis of the outcomes of primary head and neck malignancy after pulmonary metastasectomyHsueh-Ju Lu, Chih-Cheng Hsieh, Chi-Chun Yeh, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 15, 2015
Gene Expression Profiling and Pathway Network Analysis Predicts a Novel Antitumor Function for a Botanical-Derived Drug, PG2Yu-Lun Kuo, Chun-Houh Chen, Tsung-Hsien Chuang, et al.
APL Bioengineering|March 5, 2026
Hypoxia-induced drug-resistance bias 3D cancer spheroid drug screensTiger Haoran Shi, Yu-Tang Huang, Hyunsu Jeon, et al.
Journal of the Chinese Medical Association : JCMA|December 31, 2017
Toxicities, safeties and clinical response of dacarbazine-based chemotherapy on neuroendocrine tumors in Taiwan populationHwa-Yen Chiu, Liang-Yu Lin, Wen-Chi Chou, et al.
Cancer Cell International|March 27, 2025
The miR-876-5p/SOCS4/STAT3 pathway induced the expression of PD-L1 and suppressed antitumor immune responsesHsuan-Yu Peng, Yu-Li Huang, Ping-Hsiu Wu, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Cell Death Discovery|October 7, 2025
Targeting ESR1 restores SQSTM1-dependent autophagy and sensitizes ER-positive breast cancer to oxidative and radiation stressYi-Fang Yang, Zhao-Jing He, Han-Hsi Kuo, et al.
Journal of Cellular and Molecular Medicine|October 23, 2019
In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non-small-cell lung cancerTse-Hung Huang, Alexander T H Wu, Tai-Shan Cheng, et al.
Journal of the Chinese Medical Association : JCMA|April 18, 2025
Real-world experience in treatment outcome and genomic insights for metastatic prostate neuroendocrine carcinomaJiun-I Lai, Yu-Ching Peng, Peter Mu-Hsin Chang, et al.
Frontiers in Pharmacology|October 21, 2024
Dehydroepiandrosterone suppresses human colorectal cancer progression through ER stress-mediated autophagy and apoptosis in a p53-independent mannerThi-Huong Nguyen, Huey-Jiun Ko, Po-Yu Tsai, et al.
Cancer Chemotherapy and Pharmacology|May 26, 2009
Promising overall survival of patients with recurrent/metastatic squamous cell carcinoma of head and neck receiving gemcitabine plus cisplatin treatment: report of a multi-center phase II studyMuh-Hwa Yang, Peter Mu-Hsin Chang, Cheng-Hwai Tzeng, et al.
Scientific Reports|September 11, 2019
Clinical, pathophysiologic, and genomic analysis of the outcomes of primary head and neck malignancy after pulmonary metastasectomyHsueh-Ju Lu, Chih-Cheng Hsieh, Chi-Chun Yeh, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 15, 2015
Gene Expression Profiling and Pathway Network Analysis Predicts a Novel Antitumor Function for a Botanical-Derived Drug, PG2Yu-Lun Kuo, Chun-Houh Chen, Tsung-Hsien Chuang, et al.
APL Bioengineering|March 5, 2026
Hypoxia-induced drug-resistance bias 3D cancer spheroid drug screensTiger Haoran Shi, Yu-Tang Huang, Hyunsu Jeon, et al.
Journal of the Chinese Medical Association : JCMA|December 31, 2017
Toxicities, safeties and clinical response of dacarbazine-based chemotherapy on neuroendocrine tumors in Taiwan populationHwa-Yen Chiu, Liang-Yu Lin, Wen-Chi Chou, et al.
Cancer Cell International|March 27, 2025
The miR-876-5p/SOCS4/STAT3 pathway induced the expression of PD-L1 and suppressed antitumor immune responsesHsuan-Yu Peng, Yu-Li Huang, Ping-Hsiu Wu, et al.
Pageof 10